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Background: The burden of end-stage renal disease (ESRD) in the United States has increased dramatically over
the past 30 years with almost 613,000 patients receiving renal replacement therapy in 2011. That same year, more
than 112,000 new patients initiated dialysis with 92% of them receiving hemodialysis (HD). These patients experience
significant morbidity and mortality with very frequent emergency room visits. Acute hemolysis associated with
HD is a rare complication; however, if it’s not recognized early and managed adequately, it can be associated with
life-threatening complications such as hyperkalemia and even myocardial infarction.
Case presentation: 66-year-old African-American female with a history of ESRD secondary to hypertension developed
a blood infiltration on the arterial side of her arteriovenous fistula followed by sudden onset of diffuse abdominal pain
with nausea and vomiting during her regular HD treatment. She was referred to the emergency department where
she was found to have shortness of breath with improved gastrointestinal symptoms. Her initial work-up revealed a
severe anemia with a hematocrit of 10%. Further work-up revealed massive hemolysis, likely mechanical in nature
and believed to be induced by malpositioning of her HD needle in the fistula. Her hospital course was complicated
by rhabdomyolysis and acute myocardial infarction thought to be secondary to supply–demand ischemia in the
setting of her profound anemia. Within a week, she eventually had a full recovery.
Conclusion: It is extremely important for physicians and particularly emergency department physicians to be
aware of this potentially life-threatening complication of HD and have a high index of suspicion in the setting of
acute anemia with hemolysis in this population.
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The burden of ESRD in the United States has increased
dramatically over the past 30 years with almost 613,000
patients receiving renal replacement therapy in 2011. That
same year, more than 112,000 new patients initiated
dialysis with 92% of them receiving HD [1]. These patients
experience significant morbidity and mortality with
very frequent emergency room visits. Acute hemolysis
associated with HD is a rare complication; however, if
it’s not recognized early and managed adequately, it can
be associated with life-threatening complications such
as hyperkalemia and even myocardial infarction [2].* Correspondence: bjaar@aol.com
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A 66-year-old African-American female with a two-year
history of ESRD presumed secondary to longstanding
hypertension was in her usual state of health until her
HD treatment on the day of admission. She is known to
have well-controlled anemia of chronic kidney disease
treated with darbepoetin alfa without iron deficiency.
Her high blood pressure has been stable on metoprolol
tartrate and nifedipine. She had one prior history of
congestive heart failure in the setting of fluid overload but
no documented history of atherosclerotic cardiovascular
disease. She took sevelamer carbonate regularly with
her meals to control her hyperphosphatemia. No new
medications were added to her medical regimen over
the past several weeks prior to her hospitalization. On
the day of admission, she had a routine HD treatment
start; however within two hours into her regular HD
session, she developed sudden onset of diffuse abdominaltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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reportedly the patient remained hemodynamically stable,
the dialysis session was immediately interrupted and she
was found to have blood infiltration around the arterial
needle insertion site of her left upper arm arteriovenous
fistula. Her symptoms resolved spontaneously and she
went home with her daughter. Within the hour and while
at home, the patient started feeling very weak, nauseated
and had new onset of red colored urine. Subsequently, she
became cyanotic with shortness of breath. Because of
these symptoms, emergency medical services were called
and she was brought to our emergency department.
During her initial evaluation, she was afebrile and
her vital signs were significant for a blood pressure of
154/86 mmHg, a heart rate of 96 beats per minute,
respiratory rate of 20 breaths per minute, and oxygen
saturation of 97% on 3 liters of oxygen via nasal cannula.
Her physical examination was otherwise unremarkable
except for bruising and hematoma 2 cm × 2.5 cm over
her HD vascular access. Many of the laboratory values
obtained in the emergency room were initially limited
due to interference (Table 1). However, her hematocrit
was 10%, with a platelet count of 487,000 per microliter.
During her follow-up work-up, the hematocrit level was
confirmed to be 10% but the platelet count dropped
significantly to 79,000 per microliter and her peripheral
smear showed many schistocytes. The patient hemolytic
panel was consistent with hemolysis; haptoglobin was
less than 30 mg/dL; fibrin split products greater than
20 g/mL and a lactate dehydrogenase of 1,722 IU/L.
Prothrombin time and partial thromboplastin time were
normal. Her serum potassium was 4 mmol/L. Her fecal
occult blood test was negative. Thrombotic thrombocyto-
penic purpura was considered in the differential diagnosis
but ruled out due to the patient’s appropriate response
to blood transfusion therapy and lack of neurologic
symptoms. Given the patient’s elevated myoglobin, which
peaked at 3,101 ng/ml, a rheumatologic workup was
ordered and found to be normal. A muscle biopsy showed
scattered round, polygonal and angular atrophic myofibers
consistent with nonspecific myofiber atrophy. Urine
porphobilinogen, serum copper and aluminum levelsTable 1 Timeline of pertinent laboratory data
0 hour 5 hours 48 hours Day 5 Day 10
Hemoglobin (gm/dL) * * 12.1 11.1 10.4
Hematocrit (%) 10 10 33.3 33.8 30.6
Platelet (microliter) 487,000 79,000 clumping 80,000 196,000
Lactate dehydrogenase
(IU/L)
N/A * 1722 664 N/A
Haptoglobin (mg/dL) N/A * <31 120 N/A
*Interference of laboratory values was a result of free hemoglobin producing a
red discoloration of the serum even after centrifugation.
N/A: not available. Test was not ordered at that time.were all within normal limits. Blood and urine cultures
were negative. The patient received packed red blood cells
and her hemoglobin and hematocrit rose appropriately.
Her hospital course was complicated by an acute myocar-
dial infarction thought to be secondary to supply–demand
ischemia in the setting of her profound anemia. She
eventually had a full recovery and was discharged from
the hospital within one week. Subsequent dialysis sessions
were managed with extra care and were uneventful.
Our patient experienced a severe case of hemolysis
associated with HD. This is an uncommon complication
of HD but it can be associated with significant morbidity
and even death if not recognized early. Hemolysis in this
context may be a consequence of a number of biochemical,
toxic and mechanical complications during the HD pro-
cedure itself. Four major mechanisms capable of inducing
hemolysis during HD have been recognized: overheating,
hypotonicity of the dialysate, contamination of the dialys-
ate with toxins (e.g., formaldehyde, bleach, chloramine,
nitrates) from the water supply, with copper from copper
piping and improperly functioning clamps or tubing, such
as kinked arterial lines [3-6]. In cases where there is a con-
tamination of the water supply, most of the patients in the
concurrent dialysis session can experience similar signs
and symptoms associated with hemolysis [4]. Toxins can
also include contamination of the dialysate with bacteria,
endotoxins, and disinfectants although hemolysis due to
these toxins is very rare. In one simulated HD study where
post HD blood samples were run through faulty tubing,
gross hemolysis occurred within thirty minutes [7].
If faulty tubing was the culprit, one would expect to
find sporadic events linked to the manufacturer of these
supplies. Further, if biochemical or toxic causes were
associated with this event, one would expect to see other
patients with similar symptoms and hemolysis. Kinked
HD blood lines have been associated with sporadic
episodes of hemolysis during HD. However, we believe
that this unfortunate event in our patient was induced
by malpositioning of the needle on the arteriovenous
fistula, particularly given the abrupt onset of symptoms
within hours after starting HD, absence of kinked blood
lines at the time of the event, presence of blood infiltra-
tion with hematoma at the needle insertion site and
that this was again a completely isolated event since no
other patients suffered this complication. This hemolytic
phenomenon is sometimes called “red cell fragmentation
syndrome” because the hemolysis is in large part due to
intravascular mechanical injury with destruction of the
red blood cells.
Our patient presented with a critical hematocrit level;
this seems unique among most HD induced hemolysis
cases reported. Other case reports have usually described
only minor decrease in hematocrit. This major hemolytic
event with hypoxemia may explain the cause of her
Table 2 Clinical pearls of hemodialysis-induced hemolysis for the emergency medicine physician
1. Presentation: ● Hemodialysis–induced hemolysis can be very subtle
● If a dialysis patient presents acutely during hemodialysis treatment with nausea, vomiting, and abdominal pain,
be sure to have a high suspicion for this condition
2. Recognition: ● Emergency department physicians need to be aware of this hemodialysis complication in order to begin timely management
3. Differentials: ● Mechanical vs. Chemical
● Think of the 3 C’s: Chlorine, Copper, and Chloramine
4. Intervention: In the hemodialysis unit:
● tubing must be clamped immediately and not returned to the patient given the risk of hyperkalemia
In the emergency department:
● Confirm hemolysis
● Prepare for possible blood transfusion
● Check serum potassium
Prepare for hyperkalemia treatment, including hemodialysis
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to our knowledge has not been described in other HD-
induced hemolysis cases reported. The interference of
laboratory values was a result of free hemoglobin that
produced a red discoloration of the serum (known as
port wine) even after centrifugation. Our patient serum
potassium was not elevated, at least in part because the
dialysis staff did not reinfuse the patient’s blood back after
stopping the HD treatment.
Conclusions
The diagnosis of HD-induced hemolysis requires a high
level of suspicion. If hemolysis is suspected during HD,
the patient’s blood in the extracorporeal dialysis circuit
should not be reinfused and should be discarded. This is
an important step to lower the risk of hemolysis related
complications such as hyperkalemia and related arrhyth-
mias. In all cases, these patients should be referred to
the emergency department immediately after stopping
HD for further management including close monitoring
of hemoglobin and serum potassium since most HD
patients in the United States are treated in free standing
dialysis units where there are no clinicians (physicians and
physician extenders) on site except during their dialysis
rounds and no medical laboratory on site. Similarly in
other countries where HD sessions are sometimes per-
formed in the absence of a nephrologist, HD emergencies
may be handled by any other available physicians [8].
Given the serious nature, potentially life-threatening, of
HD-induced hemolysis, it is imperative for all physicians
and particularly emergency department physicians to keep
this possible diagnosis high in their differential diagnosis,
especially in the presence of acutely worsening anemia.
The most common presenting symptoms are non-specific
and may include nausea, vomiting, and abdominal pain.
Other symptoms may be shortness of breath, chest pain,
back pain and headaches. On physical examination, somepatients have been found to have worsening hyperten-
sion [6]. Differential diagnoses for HD-induced hemolysis
include hemorrhage, thrombotic thrombocytopenic pur-
pura, infection, autoimmune process, and drug reactions.
In summary, HD-induced hemolysis requires imme-
diate recognition and management (Table 2); thus the
importance of dialysis staff but also emergency department
physicians awareness. Initial work-up in the emergency
department should rule out hemolysis, assess need for
blood transfusion, monitoring and treatment of hyperkale-
mia as clinically indicated [2,9]. These steps are vital, as
the severity of this complication can be catastrophic and
rapidly life threatening.Consent
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